Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.1.7 (
acetylcholinesterase
)
28,390
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Choline and methionine are precursors of acetylcholine, whose hydrolysis is catalyzed by
acetylcholinesterase
(
AChE
). Considering the possibility of their common deficiency, we investigated the influence of methionine-choline deprivation on
AChE
activity in liver and various brain regions (hypothalamus, hippocampus, cerebral cortex and striatum) in mice fed with methionine-choline deficient (MCD) diet. Male C57BL/6 mice (n = 28) were randomly and equally divided into following groups: control group fed with standard diet for 6 weeks (C) and groups fed with MCD diet for 2 weeks (MCD2), 4 weeks (
MCD4
) and for 6 weeks (MCD6). After the diet, mice were sacrificied and
AChE
activity in liver and brain was determined spectrophotometrically. Hepatic
AChE
activity was higher in MCD2,
MCD4
and MCD6 compared to control (p < 0.01), with most prominent increase in MCD6.
AChE
activity in hypothalamus was higher in
MCD4
and MCD6 vs. control (p < 0.05 and p < 0.01, respectively), as well as in MCD6 compared to
MCD4
(p < 0.01). In hippocampus, increase in
AChE
activity was shown in MCD6 compared to control (p < 0.01). In cortex and striatum, increase in
AChE
activity was noted in MCD6 compared to control (p < 0.05). Our findings indicate the increase of hepatic and brain
AChE
activity in mice caused by methionine-choline deprivation.
...
PMID:Methionine-choline deprivation alters liver and brain acetylcholinesterase activity in C57BL6 mice. 2717 97